Equipped with a biosafety room (BSL-2/P2 compliant), capable of handling a wide range of virus vector species.
Our company is capable of conducting quality testing for gene therapy products (virus vector-related) using analysis equipment managed in compliance with GMP regulations. We provide quality testing services based on the guidelines for virus vector-related products, specifically "Guidelines for Ensuring the Quality and Safety of Gene Therapy Products," Chapter 3 Quality, Section 4. Characterization and Standards and Testing Methods. The target samples include in vivo gene therapy products and in vivo virus therapy products. 【Features】 - Comprehensive support for virus vector-related quality testing - Equipped with a biosafety room (BSL-2/P2 compliant), capable of handling a wide range of virus vector types - Possession of analysis equipment managed in compliance with GMP regulations For more detailed information, please refer to the "Related Links."
Inquire About This Product
basic information
If you have any questions or inquiries, please feel free to contact us through the "Contact Us" section on this page or via the "Contact Form" on our official website.
Price range
Delivery Time
Applications/Examples of results
For more details, please contact us.
Company information
We are a contract analysis laboratory (Kyoto) that complies with pharmaceutical GMP standards, part of the Eurofins Group, which operates a global contract analysis business. We efficiently and swiftly respond to various testing needs from the early stages of product development to commercialization, while adhering to various regulations. Please feel free to contact us if you have any requests.
![[English Market Research Report] Global Market for Biofuel Testing Services](https://image.mono.ipros.com/public/product/image/225/2001063405/IPROS13284221076060909981.png?w=280&h=280)
